BR112012033695A2 - tratamento com l-metilfolato para distúrbios psiquiátricos ou neurológicos. - Google Patents

tratamento com l-metilfolato para distúrbios psiquiátricos ou neurológicos.

Info

Publication number
BR112012033695A2
BR112012033695A2 BR112012033695A BR112012033695A BR112012033695A2 BR 112012033695 A2 BR112012033695 A2 BR 112012033695A2 BR 112012033695 A BR112012033695 A BR 112012033695A BR 112012033695 A BR112012033695 A BR 112012033695A BR 112012033695 A2 BR112012033695 A2 BR 112012033695A2
Authority
BR
Brazil
Prior art keywords
methylfolate
disorder
treatment
psychiatric
neurological disorders
Prior art date
Application number
BR112012033695A
Other languages
English (en)
Inventor
Robert L Quillin
Original Assignee
Robert L Quillin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert L Quillin filed Critical Robert L Quillin
Publication of BR112012033695A2 publication Critical patent/BR112012033695A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

tratamento com l-metilfolato para distúrbios psiquiátricos ou neurológicos. aqui são porporcionados métodos de tratamento de desaordens neuropsiquátricas ou melhorar os sintomas associados com a mesma à administração de um alimento medicinal, tal como l-metilfolato, a um sujeito tendo a desordem. o tratamento neuropsiquiátrico pode ser um transtorno de espectro do autismo ou transtorno de déficit de atenção com ou sem hiperatividade (add/adhd). a l-metilfolato pode ser administrada como um adjuvante de outros agentes terapêuticos eficazes para o tratamento da desordem. o individuo pode de preferência ser uma criança e também pode ter um polimorfismo de um único nucleotídeo no gene mthfr associado com expressão reduzida de enzima mthfr. também é fornecido um método para aumentar a síntese de novo de neurotransmissores in vivo, transportando um composto metil-doador através da barreira sanguínea encefálica de um indivíduo.
BR112012033695A 2010-07-01 2011-06-09 tratamento com l-metilfolato para distúrbios psiquiátricos ou neurológicos. BR112012033695A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/803,643 US20120004238A1 (en) 2010-07-01 2010-07-01 L-methylfolate treatment for psychiatric or neurologic disorders
PCT/US2011/039700 WO2012003073A1 (en) 2010-07-01 2011-06-09 L-methylfolate treatment for psychiatric or neurologic disorders

Publications (1)

Publication Number Publication Date
BR112012033695A2 true BR112012033695A2 (pt) 2016-11-01

Family

ID=45400162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012033695A BR112012033695A2 (pt) 2010-07-01 2011-06-09 tratamento com l-metilfolato para distúrbios psiquiátricos ou neurológicos.

Country Status (6)

Country Link
US (2) US20120004238A1 (pt)
EP (1) EP2588146A4 (pt)
BR (1) BR112012033695A2 (pt)
CA (1) CA2804016A1 (pt)
MX (1) MX2013000079A (pt)
WO (1) WO2012003073A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170073753A1 (en) * 2013-06-11 2017-03-16 Courtagen Life Sciences, Inc. Methods and kits for treating and classifying individuals
US20150132273A1 (en) * 2013-11-09 2015-05-14 Rhett Sean Daniels Nutritional Compositions and Methods for Treating Cognitive Impairment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2470299A (en) * 1998-01-27 1999-08-09 Nutramax Laboratories, Inc. Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances
US6912492B1 (en) * 1999-05-25 2005-06-28 University Of Medicine & Dentistry Of New Jersey Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
WO2006119589A2 (en) * 2005-05-11 2006-11-16 Ramaekers, Vincent Prevention and therapy of cerebral folate deficiency

Also Published As

Publication number Publication date
US20120004238A1 (en) 2012-01-05
MX2013000079A (es) 2013-05-17
CA2804016A1 (en) 2012-01-05
EP2588146A1 (en) 2013-05-08
WO2012003073A1 (en) 2012-01-05
US20120010210A1 (en) 2012-01-12
US8389535B2 (en) 2013-03-05
EP2588146A4 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
Kerner et al. Current electroconvulsive therapy practice and research in the geriatric population
EA201490279A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
MY166890A (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
NZ598137A (en) Oxazine derivatives and their use in the treatment of neurological disorders
AR082150A1 (es) N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolin-3-carboxamida deuterada, sales y usos de la misma, metodo de tratamiento, mezcla compuestos, composicion farmaceutica, proceso de preparacion, compuesto enriquecido con deuterio
BR112014027010A2 (pt) uso de laquinimod de alta dose para tratamento de esclerose múltipla
BRPI0712322A2 (pt) compostos e combinações destes para a inibição da produção de beta-amilóide e métodos de uso dos mesmos
AU2012286851A8 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
BRPI0514397A (pt) derivados de 3-ariltioindol-2-carboxamida e análogos destes como inibidores de caseìna cinase iépsilon
RU2013145551A (ru) Комбинация олигонуклеотида анти-кластерина с антагонистом рецептора андрогена для лечения рака предстательной железы
Barteček et al. Emotional impulsivity is connected to suicide attempts and health care utilization in patients with borderline personality disorder.
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
US20150335624A1 (en) Compositions and methods for using huperzine and analogs thereof
BR112012033695A2 (pt) tratamento com l-metilfolato para distúrbios psiquiátricos ou neurológicos.
BR112014014802A2 (pt) composto, composição farmacêutica, uso de um composto, métodos para tratamento ou para alívio de uma doença ou de um distúrbio ou de uma condição, e para tratamento ou melhora de doenças ou de condições
JP2013520447A5 (pt)
EP2588630A4 (en) MOLECULAR GENETIC APPROACH FOR THE TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG INDEPENDENCE
Velosa et al. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach
Kadoi Selection of anesthetics and muscle relaxants for electroconvulsive therapy
McGovern et al. Herbal medicine--sets the heart racing!
Herlina et al. Atypical antipsychotic induced weight gain in schizophrenic patients
Raval et al. Typical neuroleptic malignant syndrome presented in patient on maintenance quetiapine
Ducharme-Crevier et al. Childhood stroke and congenital heart disease
Manjunatha et al. Recurrent opisthotonus in catatonia: An atypical presentation
Amerio et al. Long-term treatment of bipolar disorder: The controversial role of antidepressants

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]